Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, providing promising breakthroughs across different professional medical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, additional reputable option for therapeutic